CEO Wei He, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Largest Shareholder Sees Value of Holdings Go Down 12% After Recent Drop
CEO Wei He, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Largest Shareholder Sees Value of Holdings Go Down 12% After Recent Drop
Key Insights
主要見解
- Insiders appear to have a vested interest in Liaoning He Eye Hospital Group's growth, as seen by their sizeable ownership
- 51% of the business is held by the top 5 shareholders
- Past performance of a company along with ownership data serve to give a strong idea about prospects for a business
- 從股東的股份佔比來看,內部人員似乎對遼寧河眼醫院集團的增長有着極其重要的利益。
- 前五大股東持有公司51%股份
- 公司過去的業績以及所有權數據,有助於形成對業務前景的強烈想法。
If you want to know who really controls Liaoning He Eye Hospital Group Co., LTD. (SZSE:301103), then you'll have to look at the makeup of its share registry. With 39% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
如果你想知道真正控制遼寧河眼醫院集團股份有限公司(深交所:301103)的是誰,那麼你就需要看看他們的股東名冊。擁有39%的股權,個人內部人員在公司中擁有最多的股份。換句話說,該集團將從他們對公司的投資中獲得最多(或損失最多)利益。
And last week, insiders endured the biggest losses as the stock fell by 12%.
上週,內部人最大的損失是股價下跌了12%。
Let's take a closer look to see what the different types of shareholders can tell us about Liaoning He Eye Hospital Group.
讓我們來仔細看看不同類型的股東對遼寧和眼科醫院集團能夠告訴我們什麼。
What Does The Institutional Ownership Tell Us About Liaoning He Eye Hospital Group?
機構持股告訴我們什麼關於遼寧和眼科醫院集團?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。
We can see that Liaoning He Eye Hospital Group does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Liaoning He Eye Hospital Group's historic earnings and revenue below, but keep in mind there's always more to the story.
我們可以看到遼寧和眼科醫院集團確實有機構投資者,他們持有公司的大部分股票。這意味着爲這些機構工作的分析師們已經研究過這支股票,並且他們喜歡它。但就像其他人一樣,他們也可能會犯錯。當多個機構持有一隻股票時,總會存在着它們在一次「擁擠交易」中的風險。當這樣的交易出現問題時,多方可能會競相快速賣出股票。在一個沒有增長曆史的公司中,這種風險更大。你可以在下面看到遼寧和眼科醫院集團的歷史收益和營業收入,但請記住故事永遠還有更多內容。
Hedge funds don't have many shares in Liaoning He Eye Hospital Group. Looking at our data, we can see that the largest shareholder is the CEO Wei He with 19% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 12% and 7.7%, of the shares outstanding, respectively.
對於遼寧河眼醫院集團,對沖基金並不持有很多股份。從我們的數據來看,最大的股東是CEO魏赫,持有19%的流通股份。同時,第二和第三大股東分別持有12%和7.7%的流通股份。
To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
爲了使我們的研究更有趣,我們發現前5位股東控制了該公司超過一半的股份,這意味着該組人對公司的決策具有相當大的影響力。
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
研究機構持股是衡量和過濾股票預期表現的一種好方法。通過研究分析師的情緒也可以實現相同的目標。我們目前沒有注意到該股票的任何分析師報告,因此該公司不大可能被廣泛持有。
Insider Ownership Of Liaoning He Eye Hospital Group
遼寧河眼醫院集團的內部所有權
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
雖然「內部人士」的明確定義具有主觀性,但幾乎所有人都認爲董事會成員是內部人士。公司管理業務,但首席執行官即使是董事會成員,也要向董事會負責。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。
Our most recent data indicates that insiders own a reasonable proportion of Liaoning He Eye Hospital Group Co., LTD.. Insiders own CN¥1.2b worth of shares in the CN¥3.0b company. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.
我們最新的數據顯示,內部人員擁有遼寧和視醫院集團有限公司相對合理的股份。內部人員持有價值12億人民幣的股票,佔該30億人民幣公司的一部分。看到內部人員如此投資於業務是非常好的。值得注意的是,這些內部人員最近是否一直在買入。
General Public Ownership
一般大衆所有權
The general public-- including retail investors -- own 25% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
普通公衆(包括零售投資者)擁有該公司25%的股份,並因此不能輕視他們。雖然這種持股規模可能不足以扭轉政策決策,但他們仍然可以對公司政策產生集體影響。
Private Equity Ownership
股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。
Private equity firms hold a 12% stake in Liaoning He Eye Hospital Group. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.
股權投資公司持有遼寧和睛眼科醫院集團12%的股份。這表明他們可以在關鍵政策決策上發揮影響力。一些投資者可能會因此感到振奮,因爲股權投資公司有時能夠鼓勵制定戰略,幫助市場看到公司的價值。另一方面,這些持有者可能在將其公開後退出投資。
Private Company Ownership
私有公司的所有權
It seems that Private Companies own 13%, of the Liaoning He Eye Hospital Group stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
似乎私營公司擁有遼寧和睛眼科醫院集團13%的股份。這可能值得進一步深入了解。如果內部人員等相關方對其中一傢俬營公司有興趣,那麼應在年度報告中披露。私營公司可能還對該公司有戰略上的興趣。
Public Company Ownership
上市公司所有權
We can see that public companies hold 5.0% of the Liaoning He Eye Hospital Group shares on issue. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.
我們可以看到上市公司持有遼寧和睛眼科醫院集團發行股份的5.0%。這可能是一種戰略性的利益,這兩家公司可能有相關的業務利益。他們可能已進行了分拆。這個持股可能值得進一步調查。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand Liaoning He Eye Hospital Group better, we need to consider many other factors. Be aware that Liaoning He Eye Hospital Group is showing 3 warning signs in our investment analysis , and 2 of those are concerning...
值得考慮的是,不同的群體持有一家公司的股份。但是爲了更好地理解遼寧閤眼醫院集團,我們需要考慮許多其他因素。請注意,遼寧閤眼醫院集團在我們的投資分析中顯示了3個警告信號,其中2個是令人擔憂的...
If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.
如果您更喜歡覈對具有潛在優越財務狀況的其他公司,則不要錯過此免費的備有強大財務數據支持的有趣公司列表。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。